KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Debt Ratio (2016 - 2020)

Historic Debt Ratio for Nektar Therapeutics (NKTR) over the last 10 years, with Q1 2020 value amounting to 0.27.

  • Nektar Therapeutics' Debt Ratio rose 13608.23% to 0.27 in Q1 2020 from the same period last year, while for Mar 2020 it was 0.27, marking a year-over-year increase of 13608.23%. This contributed to the annual value of 0.25 for FY2019, which is 12143.85% up from last year.
  • Latest data reveals that Nektar Therapeutics reported Debt Ratio of 0.27 as of Q1 2020, which was up 13608.23% from 0.25 recorded in Q4 2019.
  • In the past 5 years, Nektar Therapeutics' Debt Ratio registered a high of 0.57 during Q3 2016, and its lowest value of 0.11 during Q2 2018.
  • Over the past 5 years, Nektar Therapeutics' median Debt Ratio value was 0.42 (recorded in 2017), while the average stood at 0.33.
  • In the last 5 years, Nektar Therapeutics' Debt Ratio plummeted by 7928.09% in 2018 and then soared by 13608.23% in 2020.
  • Over the past 5 years, Nektar Therapeutics' Debt Ratio (Quarter) stood at 0.43 in 2016, then grew by 12.59% to 0.48 in 2017, then plummeted by 76.17% to 0.11 in 2018, then surged by 121.44% to 0.25 in 2019, then rose by 6.0% to 0.27 in 2020.
  • Its Debt Ratio stands at 0.27 for Q1 2020, versus 0.25 for Q4 2019 and 0.12 for Q3 2019.